• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对继发性甲状旁腺功能亢进多种解释的研究。

An examination of multiple explanations for secondary hyperparathyroidism
.

作者信息

Phelps Kenneth R, Mason Darius L

出版信息

Clin Nephrol. 2020 Aug;94(2):70-77. doi: 10.5414/CN110043.

DOI:10.5414/CN110043
PMID:32567541
Abstract

AIMS

Seven theories address the evolution of secondary hyperparathyroidism (SHPT) as chronic kidney disease (CKD) progresses. The tradeoff-in-the-nephron hypothesis states that the plasma parathyroid hormone ([PTH]) concentration rises because an increased phosphate concentration in the cortical distal nephron ([P]) reduces the ionized calcium concentration in that segment. In the present study, we compared this hypothesis to its predecessors.

MATERIALS AND METHODS

We studied 30 patients with estimated glomerular filtration rate (eGFR) less than 60 mL/min/1.73m (mean 29.5). To examine historic theories, we performed regressions of [PTH] on plasma concentrations of ionized calcium, phosphorus, 1,25-dihydroxyvitamin D, 25-hydroxyvitamin D, and fibroblast growth factor 23, and on calcium excreted per volume of filtrate (E/C). To assess the tradeoff-in-the-nephron hypothesis, we examined regressions of [PTH] on 100/eGFR and phosphorus excreted per volume of filtrate (E/C).

RESULTS

Regressions pertinent to historic theories yielded significant direct relationships between [PTH] and both E/C and [FGF23], but neither association supported the theory to which it pertained. [PTH] varied directly with 100/eGFR and with E/C, a surrogate for [P]. E/C correlated strongly with 100/eGFR.

CONCLUSIONS

The only theory of SHPT that our data support is the tradeoff-in-the-nephron hypothesis. Other theories are not supported.

摘要

目的

有七种理论阐述了随着慢性肾脏病(CKD)进展,继发性甲状旁腺功能亢进(SHPT)的演变过程。肾单位权衡假说认为,血浆甲状旁腺激素([PTH])浓度升高是因为皮质远端肾单位中磷酸盐浓度([P])增加,降低了该节段的离子钙浓度。在本研究中,我们将这一假说与其之前的理论进行了比较。

材料与方法

我们研究了30例估计肾小球滤过率(eGFR)低于60 mL/min/1.73m²(平均29.5)的患者。为检验既往理论,我们对[PTH]与血浆离子钙、磷、1,25-二羟维生素D、25-羟维生素D、成纤维细胞生长因子23的浓度,以及每单位滤液中排出的钙(E/C)进行了回归分析。为评估肾单位权衡假说,我们对[PTH]与100/eGFR以及每单位滤液中排出的磷(E/C)进行了回归分析。

结果

与既往理论相关的回归分析显示,[PTH]与E/C和[FGF23]均呈显著正相关,但这两种关联均不支持其所属的理论。[PTH]与100/eGFR以及作为[P]替代指标的E/C直接相关。E/C与100/eGFR密切相关。

结论

我们的数据支持的SHPT唯一理论是肾单位权衡假说。其他理论未得到支持。

相似文献

1
An examination of multiple explanations for secondary hyperparathyroidism
.对继发性甲状旁腺功能亢进多种解释的研究。
Clin Nephrol. 2020 Aug;94(2):70-77. doi: 10.5414/CN110043.
2
Tradeoff-in-the-Nephron: A Theory to Explain the Primacy of Phosphate in the Pathogenesis of Secondary Hyperparathyroidism.肾单位中的权衡:一种解释磷酸盐在继发性甲状旁腺功能亢进发病机制中首要地位的理论。
Nutrients. 2017 Apr 26;9(5):427. doi: 10.3390/nu9050427.
3
Use of sevelamer to examine the role of intraluminal phosphate in the pathogenesis of secondary hyperparathyroidism.使用司维拉姆研究管腔内磷酸盐在继发性甲状旁腺功能亢进发病机制中的作用。
Clin Nephrol. 2014 Sep;82(3):191-201. doi: 10.5414/cn108227.
4
Chemical evidence for the tradeoff-in-the-nephron hypothesis to explain secondary hyperparathyroidism.化学证据支持肾单位内权衡假说解释继发性甲状旁腺功能亢进症。
PLoS One. 2022 Aug 1;17(8):e0272380. doi: 10.1371/journal.pone.0272380. eCollection 2022.
5
Phosphate homeostasis, parathyroid hormone, and fibroblast growth factor 23 in stages 3 and 4 chronic kidney disease.3期和4期慢性肾脏病中的磷稳态、甲状旁腺激素和成纤维细胞生长因子23
Clin Nephrol. 2016 May;85(5):251-61. doi: 10.5414/CN108686.
6
Parathyroid Hormone, Fibroblast Growth Factor 23, and Parameters of Phosphate Reabsorption.甲状旁腺激素、成纤维细胞生长因子 23 和磷酸盐重吸收参数。
Am J Nephrol. 2018;47(5):343-351. doi: 10.1159/000489270. Epub 2018 May 18.
7
Tubular calcium reabsorption and other aspects of calcium homeostasis in primary and secondary hyperparathyroidism.原发性和继发性甲状旁腺功能亢进症中肾小管钙重吸收及钙稳态的其他方面
Clin Nephrol. 2014 Aug;82(2):83-91. doi: 10.5414/CN108223.
8
Current recommended 25-hydroxyvitamin D targets for chronic kidney disease management may be too low.目前推荐的用于慢性肾脏病管理的25-羟基维生素D目标值可能过低。
J Nephrol. 2016 Feb;29(1):63-70. doi: 10.1007/s40620-015-0186-0. Epub 2015 Mar 4.
9
Rationale for Raising Current Clinical Practice Guideline Target for Serum 25-Hydroxyvitamin D in Chronic Kidney Disease.提高慢性肾脏病患者血清 25-羟维生素 D 现行临床实践指南靶目标的理由。
Am J Nephrol. 2019;49(4):284-293. doi: 10.1159/000499187. Epub 2019 Mar 15.
10
Elderly patients with chronic kidney disease have higher risk of hyperparathyroidism.老年慢性肾脏病患者发生甲状旁腺功能亢进的风险更高。
Int Urol Nephrol. 2017 Oct;49(10):1815-1821. doi: 10.1007/s11255-017-1650-7. Epub 2017 Jul 10.